Cardiovascular Research Advance Access [Accepted Manuscript] published online on March 18, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn079
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FK506 can activate TGF-β signaling in vascular smooth muscle cells and promote proliferation
1 Invasive Cardiology Unit, Clinica Pineta Grande, Castelvolturno, Italy
2 Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples, Italy
3 Institute of Endocrinology and Experimental Oncology, Italian National Research Council (CNR), Naples, Italy
Corresponding author: Maria Fiammetta Romano, MD, Department of Biochemistry and Medical Biotechnologies, Federico II University, via Pansini, 5. 80131. Naples, Italy. Phone: +39/0817463125. Fax: +39/0817463205. Email: romano{at}dbbm.unina.it
Aims: FK506 binding protein (FKBP) 12 is an inhibitor of transforming growth factor (TGF)-β type I receptors. Several lines of evidence support the view that TGF-β stimulates vascular smooth muscle cell (VSMC) proliferation and matrix accumulation. We investigated the effect of FK506, a macrolide compound isolated from Streptomyces tsukubaensis, on cellular proliferation and on matrix protein production in human VSMCs.
Methods: We measured cell proliferation with flow cytometry using BrdU incorporation and fluorimetrically by measuring DNA concentration with Hoechst 33258. Western blot assay of whole cell lysates was used to measure the levels of signaling proteins involved in proliferative pathways, in particular β-catenin, pErk, pAkt, pmTOR and cyclin D1. Collagen synthesis was also investigated by Western blotting. The TGF-β signal was studied by both Western blotting and confocal microscopy. We used the SiRNA technique for FKBP12 gene silencing.
Results: Our results show that FK506 stimulates VSMC proliferation and collagen type I production. FK506 enhanced β-catenin levels and activated the Erk, Akt and mTOR kinases, which are important effectors of proliferation. Accordingly, cyclin D1 expression was increased. We also demonstrate that FK506 activates the TGF-β signal in VSMCs and that, through this mechanism, it stimulates cell proliferation.
Conclusion: FK506 can act as a growth factor for VSMCs.
Time for primary review: 32 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Vorpahl, A. V. Finn, M. Nakano, and R. Virmani Do We Really Understand Pimecrolimus? J. Am. Coll. Cardiol. Intv., October 1, 2009; 2(10): 1025 - 1027. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jarvelainen, A. Sainio, M. Koulu, T. N. Wight, and R. Penttinen Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy Pharmacol. Rev., June 1, 2009; 61(2): 198 - 223. [Abstract] [Full Text] [PDF]
|
|